Skip to search formSkip to main contentSkip to account menu

Epogen

National Institutes of Health

Related topics

Related topics

5 relations

Broader (2)

Epoetin AlfaErythropoietin
Epoetin Alfa 10000 UNT/ML Injectable Solution [Epogen]ProcritRecombinant Erythropoietin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Pharmacokinetic and Pharmacodynamic Equivalence of Epoetin Hospira and Epogen After Single Subcutaneous Doses to Healthy Male Subjects.
2016
2016
Pharmacodynamic and Pharmacokinetic Equivalences of Epoetin Hospira and Epogen(®) After Multiple Subcutaneous Doses to Healthy Male Subjects.
2012
2012
Affymax poised to challenge Amgen
377 peptide chains ((AcG)GLYACHMGPIT(1nal)VCQPLR(MeG)K), coupled by a linker derived from iminodiacetic acid and beta alanine… 
2012
2012
UK biotech's shot in the arm
volume 30 number 5 maY 2012 nature biotechnology It is now eight years since Omontys went into formal clinical development. There… 
Review
2010
Review
2010
Decline in the use of erythropoiesis-stimulating agents: Long-term effects of regulation, reimbursement, and unfavorable data.
e13158 Background: The use of erythropoiesis-stimulating agents (ESAs) for the treatment of anemia in cancer patients underwent a… 
2009
2009
Achieving KDOQI Guidelines for Hematocrit in HIV-Infected Hemodialysis Patients
The primary cause of anemia in HIV-infected patients with ESRD is diminished production of erythropoietin. Although most patients… 
2006
2006
Care of elderly patients with chronic kidney disease
BackgroundProviding optimal care to the growing number of chronic kidney disease (CKD) patients remains a significant problem in… 
1998
1998
Pain comparison after subcutaneous administration of single-dose formulation versus multidose formulation of epogen in hemodialysis patients.
Subcutaneous (s.c.) injection is an approved route of administration for recombinant human erythropoietin (epoetin alfa). However… 
1994
1994
The anemia of microgravity and recumbency: role of sympathetic neural control of erythropoietin production.
1992
1992
Clinical experience with erythropoietin in continuous ambulatory peritoneal dialysis.
The purpose of this project was to determine a safe and effective Epogen (EPO) subcutaneous administration schedule for patients… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)